BNP Paribas Financial Markets’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.6K | Sell |
2,256
-1,396
| -38% | -$9.63K | ﹤0.01% | 3893 |
|
|
2025
Q1 | $19.4K | Sell |
3,652
-23,731
| -87% | -$126K | ﹤0.01% | 3711 |
|
|
2024
Q4 | $323K | Buy |
+27,383
| New | +$323K | ﹤0.01% | 2762 |
|
|
2023
Q1 | – | Sell |
-3
| Closed | -$11 | – | 3239 |
|
|
2022
Q4 | $11 | Hold |
3
| – | – | ﹤0.01% | 3338 |
|
|
2022
Q3 | $16 | Hold |
3
| – | – | ﹤0.01% | 3980 |
|
|
2022
Q2 | $25 | Hold |
3
| – | – | ﹤0.01% | 3412 |
|
|
2022
Q1 | $53 | Sell |
3
-7
| -70% | -$124 | ﹤0.01% | 3531 |
|
|
2021
Q4 | $191 | Sell |
10
-98
| -91% | -$1.87K | ﹤0.01% | 3498 |
|
|
2021
Q3 | $3.29K | Sell |
108
-15
| -12% | -$457 | ﹤0.01% | 3142 |
|
|
2021
Q2 | $6.74K | Sell |
123
-226
| -65% | -$12.4K | ﹤0.01% | 3184 |
|
|
2021
Q1 | $20.6K | Sell |
349
-2,040
| -85% | -$121K | ﹤0.01% | 3186 |
|
|
2020
Q4 | $89.6K | Buy |
2,389
+1,737
| +266% | +$65.1K | ﹤0.01% | 2619 |
|
|
2020
Q3 | $35.2K | Buy |
652
+414
| +174% | +$22.4K | ﹤0.01% | 3001 |
|
|
2020
Q2 | $59.8K | Sell |
238
-398
| -63% | -$100K | ﹤0.01% | 2342 |
|
|
2020
Q1 | $100K | Buy |
636
+397
| +166% | +$62.4K | ﹤0.01% | 2605 |
|
|
2019
Q4 | $39.1K | Sell |
239
-68
| -22% | -$11.1K | ﹤0.01% | 3110 |
|
|
2019
Q3 | $44.9K | Buy |
307
+98
| +47% | +$14.3K | ﹤0.01% | 2905 |
|
|
2019
Q2 | $43.5K | Sell |
209
-180
| -46% | -$37.5K | ﹤0.01% | 2887 |
|
|
2019
Q1 | $81.2K | Buy |
389
+388
| +38,800% | +$81K | ﹤0.01% | 2664 |
|
|
2018
Q4 | $93 | Sell |
1
-48
| -98% | -$4.46K | ﹤0.01% | 3511 |
|
|
2018
Q3 | $11.2K | Hold |
49
| – | – | ﹤0.01% | 3010 |
|
|
2018
Q2 | $7.47K | Sell |
49
-297
| -86% | -$45.3K | ﹤0.01% | 3268 |
|
|
2018
Q1 | $63.3K | Sell |
346
-21
| -6% | -$3.84K | ﹤0.01% | 2852 |
|
|
2017
Q4 | $78.1K | Buy |
367
+223
| +155% | +$47.5K | ﹤0.01% | 2781 |
|
|
2017
Q3 | $30.9K | Sell |
144
-11
| -7% | -$2.36K | ﹤0.01% | 2894 |
|
|
2017
Q2 | $29.2K | Buy |
+155
| New | +$29.2K | ﹤0.01% | 2942 |
|